Sort
51,570 grants matching “autoimmune disease”
Interdisciplinary Immunology Training Program
$668,434David G. Schatz · Yale University · T32 · FY2018 · AI
Ultrasound-Mediated Blood-Brain Barrier Permeabilization in Primates
$668,381Matthew Swan Lawrence · Virscio, Inc. · R44 · FY2009 · NS
ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES
$668,366Massimo T Pietropaolo · Baylor College Of Medicine · R01 · FY2017 · DK
The pregnancy transcriptome in rheumatoid arthritis
$668,256Damini Jawaheer · Children'S Hospital & Res Ctr At Oakland · R01 · FY2019 · AR
Identification and Functional Characterization of Bioactive Microbial Metabolites of Beta-Glucan Degradation
$668,248Chenthamarakshan Vasu · Medical University Of South Carolina · R01 · FY2024 · DK
Functions of LynA and LynB kinases in myeloid-cell pro-inflammatory signaling and lupus
$668,135Tanya S. Freedman · University Of Minnesota · R01 · FY2025 · AR
Rare Variants and Risk of Type 1 Diabetes
$668,098Stephen S. Rich · University Of Virginia · R01 · FY2014 · DK
Molecular Genetic Analysis Of Lymphocyte Function
$668,074David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
$668,053Toni Choueiri · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Viral infections and celiac disease pathogenesis
$668,013Bana Jabri · University Of Chicago · R01 · FY2016 · DK
Disease-modifying drugs for T2D through targeting the Unfolded Protein Response
$667,957Feroz R Papa · University Of California, San Francisco · R01 · FY2025 · DK
Autoimmunity Center of Excellence - Rochester
$667,941Ignacio E. Sanz · University Of Rochester · U19 · FY2011 · AI
The Development of RORgt Immunomodulators Targeting the TH17 Axis in IBD- Phase 2
$667,910Gordon Alton · Visionary Pharmaceuticals, Inc. · R44 · FY2015 · DK
Heart Disease in Rheumatoid Arthritis
$667,898Cynthia S Crowson · Mayo Clinic Rochester · R01 · FY2015 · AR
Regulation of human dendritic cell activation
$667,843Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$667,798Warren J Leonard · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$667,798Warren J Leonard · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$667,798Warren J Leonard · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$667,763Donald F Hunt · University Of Virginia · R37 · FY2008 · AI
Cell-free assay technologies for the identification of active compounds
$667,741Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Targeted Lymphoablation as an alternative to HSCT to cure T1D
$667,733Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2022 · DK
MHC variation at high resolution in multiple sclerosis
$667,694Jorge R. Oksenberg · University Of California, San Francisco · R01 · FY2017 · NS
Utilizing IgG Autoantibodies As Biomarkers In IgA Nephropathy
$667,669Janusz Tucholski · Reliant Glycosciences Llc · R44 · FY2022 · DK
TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation
$667,500Michael A. Ortega · Queen'S Medical Center · R21 · FY2023 · DK
Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease
$667,339Nisarg J. Shah · University Of California, San Diego · R01 · FY2024 · AR